Earnings Announcement Next Earnings date is expected on 08/10/2022
Last Price$11.02NASDAQ Closing Price as of 4:00PM ET 8/10/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+0.22(2.04%)
Bid (Size)$10.98 (4)
Ask (Size)$12.34 (12)
Day Low / High$10.65 - 11.14
Volume38.6 K

View Pharmaceuticals: Major IndustryPeer Comparison as of 08/10/2022


Landec Corp ( NASDAQ )

Price: $11.02
Change: +0.22 (2.04%)
Volume: 38.6 K
4:00PM ET 8/10/2022

Oil-Dri Corporation of America ( NYSE )

Price: $27.49
Change: +0.31 (1.14%)
Volume: 7.5 K
4:00PM ET 8/10/2022

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

Eastern Co ( NASDAQ )

Price: $22.01
Change: +0.27 (1.22%)
Volume: 16.0 K
12:39PM ET 8/10/2022

Lakeland Industries Inc ( NASDAQ )

Price: $15.28
Change: -0.17 (1.10%)
Volume: 33.5 K
4:00PM ET 8/10/2022

Read more news Recent News

Landec Fiscal Q4 Revenue Rises; To Be Renamed Lifecore Biomedical, Update Ticker; Names New CEO
27 minutes ago, 4:51PM ET 8/10/2022 MT Newswires

Landec (LNDC) reported late Wednesday a fiscal Q4 adjusted diluted loss of $0.01 per share, vs. breakeven in the year-ago quarter. Three analysts polled by...

--Stephens Starts Landec at Overweight With $13 Price Target
5:26AM ET 7/20/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Landec Sells Curation Foods' BreatheWay Business for $3.2 Million
5:19PM ET 6/02/2022 MT Newswires

Landec (LNDC) said late Thursday it closed the sale of its Curation Foods' assets related to BreatheWay packaging technology business for $3.2 million in...

Landec's Profitability Under Pressure Amid Macro Headwinds, Barrington Says
2:46PM ET 4/06/2022 MT Newswires

Landec (LNDC) is facing macro headwinds including inflation and supply shortages that raise concerns over the company's ability to generate operating...

View all Commentary and Analysis

Celsius Holdings Inc. (CELH) Q2 Earnings and Revenues Top Estimates
6:35PM ET 8/09/2022 Zacks

Celsius Holdings Inc. (CELH) delivered earnings and revenue surprises of 50% and 2.82%,...

Vita Coco Stock Now Looks Overpriced
8:37AM ET 8/09/2022 Seeking Alpha

Laughing Water Capital - Landec Corp. : A High Quality CDMO
5:53AM ET 7/27/2022 Seeking Alpha

Laughing Water Capital Q2 2022 Letter
1:53AM ET 7/27/2022 Seeking Alpha

Company Profile

Business DescriptionLandec Corp. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. It operates through the following segments: Curation Foods, Lifecore, and Others. The Curation Foods segment includes activities to market and pack specialty packaged whole and fresh-cut fruit and vegetables. The Lifecore segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans. The Other segment consists of corporate general and administrative expenses, non-Curation Foods and non-Lifecore interest income, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Santa Maria, CA. View company web site for more details
Address2811 Airpark Drive
Santa Maria, California 93455
Number of Employees736
Recent SEC Filing08/08/20224
President, Chief Executive Officer & DirectorAlbert D. Bolles
Chief Financial Officer & SecretaryJohn D. Morberg
Vice PresidentJames G. Hall

Company Highlights

Price Open$10.96
Previous Close$10.80
52 Week Range$7.65 - 12.04
Market Capitalization$324.9 M
Shares Outstanding29.5 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/10/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.05
Beta vs. S&P 500N/A
Revenue$557.6 M
Net Profit Margin-12.83%
Return on Equity-33.23%

Analyst Ratings as of 07/18/2022

Consensus RecommendationConsensus Icon
Powered by Factset